Greenwich LifeSciences announced that its Board of Directors has extended the lock-up of the shares owned by the Company’s directors, officers, and existing pre-IPO investors to December 31, 2023 which is approximately 39 months from date of the company’s IPO. During this period, current officers, directors and certain shareholders will not be able to sell their shares of the company’s common stock unless otherwise modified by the Board of Directors.
Published first on TheFly
